Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Other Non-Current Assets (2018 - 2025)

Precision Biosciences (DTIL) has disclosed Other Non-Current Assets for 8 consecutive years, with $26.3 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets rose 16.37% to $26.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $26.3 million through Dec 2025, up 16.37% year-over-year, with the annual reading at $26.3 million for FY2025, 16.37% up from the prior year.
  • Other Non-Current Assets for Q4 2025 was $26.3 million at Precision Biosciences, up from $200000.0 in the prior quarter.
  • The five-year high for Other Non-Current Assets was $26.3 million in Q4 2025, with the low at $200000.0 in Q3 2025.
  • Average Other Non-Current Assets over 5 years is $7.1 million, with a median of $2.8 million recorded in 2023.
  • The sharpest move saw Other Non-Current Assets surged 9944.44% in 2024, then plummeted 99.11% in 2025.
  • Over 5 years, Other Non-Current Assets stood at $4.6 million in 2021, then crashed by 95.13% to $226000.0 in 2022, then decreased by 0.44% to $225000.0 in 2023, then soared by 9944.44% to $22.6 million in 2024, then rose by 16.37% to $26.3 million in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $26.3 million, $200000.0, and $22.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.